好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effect of Degree of Caloric Imbalance on ALS Disease Progression
Neuromuscular and Clinical Neurophysiology (EMG)
S5 - Updates on Amyotrophic Lateral Sclerosis (4:42 PM-4:54 PM)
007

Caloric intake suffers in ALS patients due to poor nutrition while caloric expense is increased by hypermetabolism and inefficient use of calories during physical activity. Caloric imbalance, weakness, and fatality eventually result (1). 

To assess the effect of caloric balance on disease-severity and progression measured by change in the ALS Functional Rating Score -revised (ALSFRSR) and forced vital capacity (FVC).

Data on 103 patients from our center from are included to date. The estimated total daily caloric requirement (TDCR) was calculated using an ALS-specific version of the Harris-Benedict equation (HBE) (2) where TDCR = [(Basal Metabolic Rate from HBE) + (55.96 x ALSFRSR-6) – 168 kcal/day] (3). Caloric Balance (CB) was calculated as CB = [(daily caloric intake / TDCR) x 100]. Patients were categorized as being below, within, or above CB thresholds of 5%, 10%, 15%, and 20%. Patients were further stratified based on ALSFRSR scores, FVC, and rate of disease progression at baseline. 

Patients with TDCR >10% (p = 0.04) and >15% (p = 0.02) compared to intake had slower rates of disease progression (-0.37 and –0.47, respectively) compared to patients below or within 5% CB. Detailed results on a larger sample size will be presented later. 

Patients with positive CB >10% and >15% have slower rates of decline of ALSFRS-R scores compared to patients at or below the 5% threshold. Results have implications for early nutritional care in ALS. 

Authors/Disclosures
Syed M. Jafri
PRESENTER
Mr. Jafri has nothing to disclose.
Rachel Thompson Miss Thompson has nothing to disclose.
Muhannad Seyam, MD Dr. Seyam has nothing to disclose.
Joan Skelly (University of Vermont) Joan Skelly has nothing to disclose.
Margo Nolan, BA Miss Nolan has nothing to disclose.
Jiayi Luo Ms. Luo has nothing to disclose.
Waqar Waheed, MD, MBBS Dr. Waheed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Edward J. Kasarskis, MD, PhD, FAAN (UK Healthcare) The institution of Dr. Kasarskis has received research support from Healey Platform Trial Group. The institution of Dr. Kasarskis has received research support from Amylyx . The institution of Dr. Kasarskis has received research support from Alexion. The institution of Dr. Kasarskis has received research support from Woolsey . Dr. Kasarskis has a non-compensated relationship as a Director of ALSA-supported clinic at the University of Kentucky with ALS Association that is relevant to AAN interests or activities.
Rup Tandan, MD, FRCP, FAAN (University of Vermont (UVM)/UVM Medical Center) Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics.